BroadenBio Co., Ltd.
PrivateLast Round
VC Round
Apr 8, 2022
Company Overview
BroadenBio Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a VC Round in April 2022.
BroadenBio Co., Ltd. is a biotechnology company that focuses on the research and development of innovative drugs for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BroadenBio Co., Ltd. Comparables
Compare BroadenBio Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elpiscience Biopharmaceuticals | 80% | |
| OncoC4, Inc. | 79% | |
| Oricell Therapeutics | 78% |
For institutional investors. Book with your work email.
BroadenBio Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 8, 2022 | ||||
| VC Round | Oct 13, 2020 | ||||
| Early Funding | Apr 13, 2020 |
For institutional investors. Book with your work email.
BroadenBio Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lapam Capital | VC Round, Angel |
| Tao Capital Partners | Angel, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2022
Tao Capital Partners led the VC Round.
- Oct 13, 2020
Tao Capital Partners led the VC Round.
For institutional investors. Book with your work email.
BroadenBio Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BroadenBio Co., Ltd.'s valuation, stock price, and market status.
Is BroadenBio Co., Ltd. a public or private company?
BroadenBio Co., Ltd. is a private company.
What is the current stock price of BroadenBio Co., Ltd.?
BroadenBio Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks BroadenBio Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BroadenBio Co., Ltd. worth (valuation)?
Valuation information for BroadenBio Co., Ltd. is not publicly available.
Can I buy BroadenBio Co., Ltd. stock?
BroadenBio Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BroadenBio Co., Ltd.'s last funding round?
BroadenBio Co., Ltd.'s most recent funding round was VC Round on April 8, 2022.
Who are the main investors in BroadenBio Co., Ltd.?
Key investors in BroadenBio Co., Ltd. include Tao Capital Partners.
Will BroadenBio Co., Ltd. IPO soon?
No public IPO plans have been announced for BroadenBio Co., Ltd..
How can I track BroadenBio Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in BroadenBio Co., Ltd.'s shares on secondary markets.